Hyperglycaemia and the very preterm baby

Area of Science:

• Neonatal Medicine
• Endocrinology
• Pediatrics

Background:

• Neonatal hyperglycemia (high blood glucose) is frequently observed in extremely preterm infants (born >12 weeks early).
• Current definitions of hyperglycemia are often based on data from term infants, potentially misrepresenting the clinical picture in preterm neonates.

Purpose of the Study:

• To evaluate the clinical relevance of the current definition of neonatal hyperglycemia in extremely preterm infants.
• To propose a more operationally relevant definition for hyperglycemia in this specific population.

Main Methods:

• Retrospective cohort review of extremely preterm infants born in the north of England.
• Analysis of blood glucose levels and corresponding urine glucose concentrations.
• Correlation of glucose levels with the risk of osmotic diuresis.

Main Results:

• Significant glycosuria (glucose in urine) was uncommon despite blood glucose levels exceeding 7 mmol/L.
• The risk of osmotic diuresis was minimal until urine glucose reached 2%, at which point blood glucose typically exceeded 15 mmol/L.
• Current definitions may overestimate the clinical significance of hyperglycemia in this cohort.

Conclusions:

• The standard definition of neonatal hyperglycemia (>7 mmol/L) may not be clinically appropriate for extremely preterm infants.
• A revised, more operationally relevant definition is needed to guide clinical management and avoid unnecessary interventions.
• Further research should focus on defining clinically meaningful thresholds for hyperglycemia in preterm neonates.